Published in Am J Gastroenterol on March 01, 1987
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
An association between sudden infant death syndrome (SIDS) and Helicobacter pylori infection. Arch Dis Child (2000) 8.02
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev (1989) 7.03
Characterization of urease from Campylobacter pylori. J Clin Microbiol (1988) 5.57
Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun (1989) 3.81
Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother (1991) 3.05
Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun (1990) 3.01
Identification, characterization, and spatial localization of two flagellin species in Helicobacter pylori flagella. J Bacteriol (1991) 2.94
Isolation and biochemical and molecular analyses of a species-specific protein antigen from the gastric pathogen Helicobacter pylori. J Bacteriol (1991) 2.69
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Campylobacter pylori and gastroduodenal disease. Clin Microbiol Rev (1990) 2.53
Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun (1995) 2.15
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut (1994) 2.10
Use of PCR with feces for detection of Helicobacter pylori infections in patients. J Clin Microbiol (1994) 2.09
Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09
Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis. Gut (1989) 2.06
Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut (1993) 1.99
The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci U S A (1995) 1.99
Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun (1996) 1.98
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut (1992) 1.96
Is Helicobacter pylori the cause of dyspepsia? BMJ (1992) 1.95
Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92
Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infect Immun (1990) 1.88
Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol (1993) 1.85
Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut (1998) 1.82
Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut (1997) 1.80
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ (1994) 1.78
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev (2006) 1.73
Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch Dis Child (1990) 1.68
Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol (1990) 1.62
Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun (1998) 1.61
Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60
Challenge model for Helicobacter pylori infection in human volunteers. Gut (2004) 1.57
Helicobacter pylori. Arch Dis Child (1990) 1.55
Naturally occurring chronic gastritis and C pylori infection in the rhesus monkey: a potential model for gastritis in man. Gut (1988) 1.52
Helicobacter mustelae isolation from feces of ferrets: evidence to support fecal-oral transmission of a gastric Helicobacter. Infect Immun (1992) 1.51
Helicobacter felis gastritis in gnotobiotic rats: an animal model of Helicobacter pylori gastritis. Infect Immun (1991) 1.51
Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut (1993) 1.47
Kyoto global consensus report on Helicobacter pylori gastritis. Gut (2015) 1.47
Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo). Infect Immun (1991) 1.46
Relation of Helicobacter pylori to the human gastric mucosa in chronic gastritis of the antrum. Gut (1990) 1.38
Serodiagnosis of Helicobacter pylori infection in childhood. J Clin Microbiol (1990) 1.31
Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut (1995) 1.30
Tightly spiral shaped bacteria in the human stomach: another cause of active chronic gastritis? Gut (1990) 1.27
Evaluation of two monkey species (Macaca mulatta and Macaca fascicularis) as possible models for human Helicobacter pylori disease. J Clin Microbiol (1990) 1.27
Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro. Infect Immun (1993) 1.25
Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut (1997) 1.24
Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut (1993) 1.24
Determination of the infectious dose of Helicobacter pylori during primary and secondary infection in rhesus monkeys (Macaca mulatta). Infect Immun (2001) 1.21
Helicobacter pylori may induce bile reflux: link between H pylori and bile induced injury to gastric epithelium. Gut (1996) 1.14
Macromolecular structure and aggregation states of Helicobacter pylori urease. J Bacteriol (1991) 1.11
A conventional beagle dog model for acute and chronic infection with Helicobacter pylori. Infect Immun (1999) 1.09
Helicobacter pylori represses proton pump expression and inhibits acid secretion in human gastric mucosa. Gut (2010) 1.08
Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ (1991) 1.06
Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K(+)-ATPase. Gut (1994) 1.06
Significance of transiently positive enzyme-linked immunosorbent assay results in detection of Helicobacter pylori in stool samples from children. J Clin Microbiol (2005) 1.05
Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun (1993) 1.05
Experimental gastritis induced by Helicobacter pylori in Japanese monkeys. Infect Immun (1993) 1.05
Hemagglutination activity of Campylobacter pylori. Infect Immun (1989) 1.04
Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J Biol Chem (2008) 1.04
High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci (1997) 1.03
Transmission of Helicobacter pylori infection. Gut (1995) 1.03
Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Helicobacter pylori is not the causative agent. BMJ (1994) 1.03
Adhesion of Helicobacter pylori to gastric epithelial cells in primary cultures obtained from stomachs of various animals. Infect Immun (1993) 1.02
Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and Helicobacter. Microbiol Mol Biol Rev (2011) 1.01
Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up. Gut (2000) 1.00
Non-immunological defence mechanisms of the gut. Gut (1992) 1.00
Subtypes of intestinal metaplasia and Helicobacter pylori. Gut (1992) 1.00
Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer. Gut (1992) 1.00
Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. J Clin Microbiol (1994) 0.99
How Helicobacter pylori infection controls gastric acid secretion. J Gastroenterol (2012) 0.99
Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut (2000) 0.99
Helicobacter pylori--our knowledge is growing. Postgrad Med J (1990) 0.98
Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori. J Clin Pathol (1992) 0.97
Helicobacter pylori: bridging the credibility gap. Gut (1990) 0.97
Seroepidemiology of Helicobacter pylori infection in vegans and meat-eaters. Epidemiol Infect (1992) 0.94
Construction of a Helicobacter pylori-Escherichia coli shuttle vector for gene transfer in Helicobacter pylori. Appl Environ Microbiol (1997) 0.93
Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol (2014) 0.93
Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence. Gut (1995) 0.91
Inhibition of acid secretion from parietal cells by non-human-infecting Helicobacter species: a factor in colonization of gastric mucosa? Infect Immun (1991) 0.89
Helicobacter pylori strain-specific modulation of gastric mucosal cellular turnover: implications for carcinogenesis. J Gastroenterol (2002) 0.88
In vivo sequence variation in HopZ, a phase-variable outer membrane protein of Helicobacter pylori. Infect Immun (2012) 0.88
Human embryonic gastric xenografts in nude mice: a new model of Helicobacter pylori infection. Infect Immun (1999) 0.87
DNA fingerprints of Helicobacter pylori before and after treatment with omeprazole. J Clin Pathol (1992) 0.87
Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents. Antimicrob Agents Chemother (1992) 0.86
Helicobacter pylori. Its role in the pathogenesis of peptic ulcer disease in a new animal model. Am J Pathol (1992) 0.86
Helicobacter pylori in children. Postgrad Med J (1991) 0.85
Construction and characterization of an isogenic urease-negative mutant of Helicobacter mustelae. Infect Immun (1995) 0.85
Immunohistochemical study of lymphocyte populations infiltrating the gastric mucosa of beagle dogs experimentally infected with Helicobacter pylori. Infect Immun (2000) 0.85
Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals. Gut (2005) 0.84
Ultrastructural study of two patterns in the interaction of Helicobacter pylori with neutrophils. J Clin Pathol (1994) 0.84
The relationship between the presence of Helicobacter pylori, Clostridium perfringens type A, Campylobacter spp, or fungi and fatal abomasal ulcers in unweaned beef calves. Can Vet J (1995) 0.84
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med (1994) 27.68
Is informed consent always necessary for randomized, controlled trials? . N Engl J Med (1999) 6.32
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia (2003) 4.33
Uses of barium meal examination in dyspeptic patients under 50. Br Med J (1977) 3.82
Inhibition of beta-lactamases by beta-lactam antibiotics. Antimicrob Agents Chemother (1972) 3.72
Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med (1994) 3.21
Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis (2001) 3.11
Has misdiagnosis of appendicitis decreased over time? A population-based analysis. JAMA (2001) 3.06
Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A (2003) 2.56
Seroepidemiology of Campylobacter pyloridis. N Z Med J (1986) 2.52
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust (1999) 2.13
Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ (1997) 2.08
Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care (1994) 2.07
Rapid diagnosis of Campylobacter pyloridis infection. Lancet (1986) 2.03
Abdominal lymph-node granulomas and Helicobacter pylori. Lancet (1993) 2.01
Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet (1999) 1.99
Fetal alcohol syndrome: a prospective national surveillance study. Arch Dis Child (2007) 1.98
Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis (2011) 1.84
Ophthalmic survey of a diabetic clinic. I: Ocular findings. Br J Ophthalmol (1986) 1.80
Interventions for impetigo. Cochrane Database Syst Rev (2004) 1.78
Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis. Ann Rheum Dis (2005) 1.77
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am J Cardiol (1997) 1.77
Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J (1997) 1.75
Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J Immunol (2000) 1.74
Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Lancet (2001) 1.64
Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol (2000) 1.63
Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med (2000) 1.62
TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology (2011) 1.56
Chemical composition of the attachment pad secretion of the locust Locusta migratoria. Insect Biochem Mol Biol (2002) 1.54
Venous and arterial gas embolism associated with positive pressure ventilation. Chest (1998) 1.52
Maintenance of lower proportions of (n - 6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fatty acids. Biochim Biophys Acta (1992) 1.50
Binding of different forms of lipopolysaccharide and gene expression in bovine blood neutrophils. J Dairy Sci (2009) 1.48
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators. Can J Cardiol (2000) 1.47
A reassessment of genetic diversity in Icelanders: strong evidence from multiple loci for relative homogeneity caused by genetic drift. Ann Hum Genet (2003) 1.43
A prospective randomised trial of absorbable versus non-absorbable sutures for wound closure after fasciectomy for Dupuytren's contracture. J Hand Surg Eur Vol (2009) 1.42
Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. J Biol Chem (1996) 1.41
Eurobloodpack: a common European design for blood bag systems with integral leucodepletion filters. Vox Sang (2011) 1.39
Microsatellite mutations and inferences about human demography. Genetics (2000) 1.37
The mode of action of novobiocin. Prog Med Chem (1971) 1.37
Correlation between hydrolysis of the -lactam bond of the cephalosporin nucleus and expulsion of the 3-substituent. J Bacteriol (1972) 1.32
Do managed clinical networks improve quality of diabetes care? Evidence from a retrospective mixed methods evaluation. Qual Saf Health Care (2009) 1.31
Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation. J Neurol Neurosurg Psychiatry (2002) 1.31
Purification and chemical characterization of staphyloferrin B, a hydrophilic siderophore from staphylococci. Biometals (1993) 1.31
Ophthalmic survey of a diabetic clinic: II. Requirements for treatment of retinopathy. Br J Ophthalmol (1986) 1.27
Contamination of endoscopes used in AIDS patients. Lancet (1989) 1.21
Regulation of cellular antibody synthesis effect of adoptively transferred antibody-producing spleen cells on cellular antibody synthesis. J Immunol (1968) 1.19
Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer (2001) 1.18
Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes. Diabetologia (2004) 1.18
Clinically significant Streptococcus anginosus (Streptococcus milleri) infections: a review of 186 cases. N Z Med J (1988) 1.17
Cytochalasin D does not produce net depolymerization of actin filaments in HEp-2 cells. Nature (1980) 1.16
Effects of monoclonal antibodies to the alpha and beta chains of the human lymphocyte function-associated (H-LFA-1) antigen on T lymphocyte functions. Eur J Immunol (1985) 1.16
Punishment-specific effects of pentobarbital: dependency on the type of punisher. J Exp Anal Behav (1977) 1.16
The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon. EMBO J (1990) 1.15
Membrane binding of phospholipases C-beta 1 and C-beta 2 is independent of phosphatidylinositol 4,5-bisphosphate and the alpha and beta gamma subunits of G proteins. Biochemistry (1996) 1.14
Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor. J Biol Chem (2000) 1.13
A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Hum Genet (2001) 1.12
Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues. Lipids (1990) 1.11
Identification of two binding sites for wheat-germ agglutinin on polylactosamine-type oligosaccharides. Biochem J (1985) 1.11
Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res (1997) 1.09
Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? Brain (2002) 1.09
Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia. Thorax (2007) 1.08
Confirmation of the novel association at the BTNL2 locus with ulcerative colitis. Tissue Antigens (2009) 1.06
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Bone Marrow Transplant (2013) 1.04
Familial Paget's disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q. Bone (2000) 1.04
Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. Am J Surg (1997) 1.03
Long-term results, hemodynamics, and complications after combined heart and lung transplantation. Circulation (1985) 1.03
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol (2001) 1.03
The isolation and characterization of a clonally related series of murine retrovirus-infected mouse cells. J Gen Virol (1980) 1.01
Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells. AIDS Res Hum Retroviruses (1992) 1.01
Primary oat cell carcinoma of the common bile duct. J R Coll Surg Edinb (1988) 1.01
Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev (2005) 1.00
Campylobacter pyloridis infection in Auckland patients with gastritis. N Z Med J (1986) 1.00
Computed tomography, ultrasound, and cholestatic jaundice. Gut (1978) 1.00
Assessment of a programme to screen the newborn for congenital hypothyroidism. Community Med (1979) 0.99
A low-temperature-responsive translation elongation factor 1 alpha from barley (Hordeum vulgare L.). Plant Mol Biol (1993) 0.99
Drug use behaviors among Asian drug users in San Francisco. Addict Behav (2000) 0.99
Screening for medium chain acyl-CoA dehydrogenase deficiency has still not been evaluated. . BMJ (2001) 0.98
Fecal leukocytes in stool specimens submitted for Clostridium difficile toxin assay. Diagn Microbiol Infect Dis (1993) 0.98
Vertebral column injuries and lap-shoulder belts. J Trauma (1995) 0.98
Progressive pulmonary insufficiency and other pulmonary complications of thermal injury. J Trauma (1975) 0.97
Campylobacter pylori infection in Meckel's diverticula containing gastric mucosa. Gut (1989) 0.97
Maternal and neonatal side-effects of remifentanil patient-controlled analgesia in labour. Br J Anaesth (2005) 0.96
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients. Arch Dis Child (2003) 0.96
B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes. Heart (2005) 0.96
Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury. Thorax (2008) 0.96
Tumour necrosis factor alpha and interleukin-1 beta induce specific subunits of NFKB to bind the HIV-1 enhancer: characterisation of transcription factors controlling human immunodeficiency virus type 1 gene expression in neural cells. Biochem Biophys Res Commun (1994) 0.95
Heart transplantation for Barth syndrome. Pediatr Cardiol (1997) 0.95
Segregation of QTL for production traits in commercial meat-type chickens. Genet Res (2004) 0.94
Transverse myelitis complicating Mycoplasma pneumoniae infection. Postgrad Med J (1977) 0.94
[Identification of amino acid phenylthiohydantoins by mass spectrometry]. Z Naturforsch B (1970) 0.94
Time use patterns among women with rheumatoid arthritis: association with functional limitations and psychological status. Rheumatology (Oxford) (2006) 0.94